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B IOPHYS IC S
Myosin-binding protein C corrects an
intrinsic inhomogeneity in cardiac
excitation-contraction coupling
Michael J. Previs,1* Benjamin L. Prosser,2* Ji Young Mun,3,4*
Samantha Beck Previs,1 James Gulick,5 Kyounghwan Lee,3 Jeffrey Robbins,5
Roger Craig,3† W. J. Lederer,6† David M. Warshaw1†
The beating heart exhibits remarkable contractile fidelity over a lifetime, which reflects the tight coupling of
electrical, chemical, and mechanical elements within the sarcomere, the elementary contractile unit. On a beat-
to-beat basis, calcium is released from the ends of the sarcomere and must diffuse toward the sarcomere center
to fully activate the myosin- and actin-based contractile proteins. The resultant spatial and temporal gradient in
free calcium across the sarcomere should lead to nonuniform and inefficient activation of contraction. We show
that myosin-binding protein C (MyBP-C), through its positioning on the myosin thick filaments, corrects this
nonuniformity in calcium activation by exquisitely sensitizing the contractile apparatus to calcium in a manner
that precisely counterbalances the calcium gradient. Thus, the presence and correct localization of MyBP-C
within the sarcomere is critically important for normal cardiac function, and any disturbance of MyBP-C localization
or function will contribute to the consequent cardiac pathologies.
INTRODUCTION
Ventricular power generation involves the rapid release of calcium
from the sarcoplasmic reticulum (SR) and diffusion of these ions through
the sarcomere to activate the contractile machinery (Fig. 1A). Each
heartbeat is initiated by an action potential that triggers the opening
of ryanodine receptors (1) (calcium release channels in the terminal
cisternae of the SR) that are located within nanometers of the Z-lines
of each sarcomere (Fig. 1A). Calcium then binds to the troponin-
tropomyosin regulatory complex to activate the actin-based thin fila-
ment so that myosin molecular motors, comprising the thick filaments,
can interact with the thin filaments (Fig. 1A) to generate force and mo-
tion (2, 3). Because of the spatial organization of the calcium release
channels and diffusion rates in the sarcomere, molecular modeling (4)
and experimental evidence from elongated frog skeletal muscle (5)
suggest that a spatiotemporal calcium gradient should exist along the
length of each cardiac sarcomere that could lead to heterogeneity in
excitation-contraction (E-C) coupling. Cardiac myosin-binding protein
C (MyBP-C) (Fig. 1B), which is considered to be a potential activator of
the thin filament (6–9), is located in a region of the sarcomere (that is,
C-zone; Fig. 1A) that would experience such temporal delays in calcium
concentrations. Therefore, we hypothesize that localization of MyBP-
C to the C-zone may mitigate potential inhomogeneities in calcium
activation.
Cardiac MyBP-C is a 140-kD immunoglobulin (Ig) protein super-
family member (Fig. 1B) that is strongly bound to the thick filament
by its C terminus, whereas its N-terminal domains extend radially (10)
to allow their binding to the thin filament and the myosin head region
that emanates from the thick filament backbone (11). In the normal
heart, MyBP-C’s M-domain contains four highly phosphorylated cardiac-
specific serine residues (Fig. 1B) (12–14). Although the role of MyBP-C
in vivo is unclear, its functional importance is evidenced by its genetic
mutations being a leading cause of hypertrophic cardiomyopathy (15)
and its decreased phosphorylation being a hallmark of the failing
heart (12, 13). Here, we have used advanced multidimensional light
microscopy techniques and analytic modeling to quantify a calcium
transient across a single sarcomere during the initial phase of cardiac
muscle contraction that would lead to a gradient in thin filament ac-
tivation. We then combined our recently developed single-particle
thick filament–based analytic platform (14) and three-dimensional (3D)
electron microscopy (EM) to determine that MyBP-C’s N-terminal do-
mains can sensitize thin filaments to calcium within the C-zone. Thus,
we propose that MyBP-C effectively normalizes an intrinsic inhomo-
geneity in E-C coupling that exists because of the sarcomeric calcium
gradient.
RESULTS
A transient calcium gradient is observed within
single sarcomeres
The locations of MyBP-C and the ryanodine receptors within isolated
mouse cardiac myocytes were visualized by EM and two-color direct
stochastic optical reconstruction microscopy (dSTORM) (16) with nano-
meter spatial resolution (Fig. 1, C and D, and fig. S1). Punctate clusters
of ryanodine receptors form calcium release units (CRUs) that reside
along the Z-lines of each sarcomere to which the thin filaments are
anchored (Fig. 1D and fig. S1), whereas MyBP-C is localized to nine
distinct stripes within each C-zone, flanking the M-line and centered
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~650 nm from the Z-line (Fig. 1, C and D). We used high-speed laser
scanning confocal microscopy (Fig. 2, A to F) to monitor the electri-
cally stimulated increase in cytosolic calcium [[Ca2+]i (intracellular cal-
cium concentration)] in 500-nm regions (Fig. 2B) encompassing either
CRUs at the Z-lines (ends of the sarcomere) or MyBP-C near the M-line
(center of the sarcomere) with 200-ms temporal resolution (16). We
identified the locations of CRUs through live cell labeling with a
fiduciary transverse tubule (t-tubule)/Z-line marker (Fig. 2, A and
B) and placed our confocal scan line directly over several confirmed
CRUs and their neighboring M-lines in series (Fig. 2B). In relaxed
myocytes, the basal level of calcium within both the Z- and M-line
regions was 90 to 105 nM [that is, −log calcium (pCa), 7.05 to 6.98],
reaching 1 to 1.4 mM (pCa 6.00 to 5.85) at the peak of contraction.
Excitation resulted in the triggering of calcium release from most,
but not all, of the CRUs on any given beat, as previously suggested
(17). Although calcium is being released from CRUs in three dimen-
sions, we are only able to resolve these events in the visual plane, and
for simplicity, we refer to the events as originating from one or both
CRUs flanking a single sarcomere. We thus separately analyzed the
time course of [Ca2+]i from sarcomeres where only one CRU was triggered
versus where two CRUs were triggered on opposing ends of an individual
sarcomere. Under physiological circumstances, a sarcomere would be
activated by only one CRU between 25 and 50% of the time, which
would also be influenced by factors such as sarcomeric calcium load,
ryanodine receptor sensitivity, and any CRU structural remodeling
(18). Within 5 ms of stimulation, calcium concentrations began to in-
crease at both the Z- and M-line regions, but with a temporal delay at
the M-line, being distant from the CRUs (Fig. 2D). This delay led to
an average calcium gradient of 60 to 140 nM from the Z- to the M-line,
with the magnitude dependent on whether calcium was released from
one or two CRUs flanking a given M-line. The calcium gradient peaked
roughly 13 ms after electrical stimulation and persisted for 20 ms before
collapsing because of diffusion (Fig. 2, E and F). Notably, contraction
was detected 8 to 10 ms after electrical stimulation.
Is this gradient intrinsic to the diffusion of calcium within the sar-
comere or an artifact of sarcomere movement? To control for poten-
tial artifacts from myocyte contraction, we repeated these experiments
in the presence of the contractile inhibitor blebbistatin. Blebbistatin
blocked myocyte contraction without qualitatively altering the sarco-
meric calcium gradient (fig. S2). The persistence of the gradient can be
explained by calcium release flux from each CRU remaining signifi-
cantly elevated for 10 to 20 ms after stimulation (19) and is consider-
ably longer-lasting than would be predicted for a calcium gradient in
skeletal muscle, where rapid channel inactivation limits release flux to
~2 ms (20).
Native thin filaments are activated by calcium
Could such temporal differences in calcium distribution within the
sarcomere create spatial gradients in contractile activation along the
length of the calcium-regulated thin filament? In a simplified model
system of cardiac contractility, we determined the concentrations over
which calcium regulates the sliding of fluorescently labeled, native
mouse cardiac thin filaments on a surface of monomeric mouse
a-cardiac myosin [25 mM KCl, 100 mMATP (adenosine triphosphate),
22°C] (16). On the basis of this in vitro motility assay, thin filaments
are highly sensitive to calcium over the range of concentrations mea-
sured in the sarcomere after excitation (pCa 7.05 to 5.85; Fig. 2D), as
evidenced by the sigmoidal increases in both the sliding velocities (fig.
S3A) and the fraction of thin filaments moving (fig. S3B and Fig. 3E).
Graded responses in both calcium-activated thin filament sliding veloci-
ties and fraction of thin filaments moving reflect the increased engage-
ment of force-generating actomyosin cross-bridges (21). However,
both velocity and fraction of thin filaments moving may not be direct-
ly proportional to the number of attached, force-generating cross-bridges
because few cross-bridges are required to propel a native thin filament
(21). Regardless, on the basis of the fraction of filaments moving (Fig.
3E), these data suggest that the observed gradient in free calcium between
the Z- and M-lines (Fig. 2, E and F) would result in thin filaments being
up to ~22% less activated near the center of the sarcomere 10 ms after
excitation. This inhomogeneity in E-C coupling could compromise
mechanical efficiency in the heart that must repetitively contract and relax
in a synchronous manner.
MyBP-C enhances thin filament activation within the C-zone
Could MyBP-C residing within the C-zone near the sarcomere center
eliminate this potential gradient in E-C coupling by effectively sensi-
tizing the thin filament to calcium? To answer this question, we isolated
native thick filaments from wild-type mouse hearts. Electron micros-
copy, Western blotting, and quantitative mass spectrometry were
Fig. 1. Sarcomeric organization and MyBP-C. (A) Cardiac muscle sarco-
mere with interdigitating thick and thin filaments. MyBP-C localized to the
C-zone, whereas the ryanodine receptors are localized in puncta (CRUs)
along the Z-lines, forming the boundaries of each sarcomere. (B) Schematic
diagram of cardiac MyBP-C’s Ig-like (oval) and fibronectin-like (rectangular)
domains with four phosphorylation sites (P) in the M-domain and C0C3
fragment (dashed box) used in the 3D EM and in vitro motility experi-
ments. (C) Negatively stained EM image of a sarcomere within a mouse
ventricular myocyte labeled with antibodies to MyBP-C. (D) Two-color
dSTORM super-resolution image of sarcomeres as in (C), labeled with Alexa
Fluor–conjugated antibodies to MyBP-C and ryanodine receptors.
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previously used to show that these native thick filaments retained
MyBP-C’s in vivo stoichiometry and spatial orientation within the
thick filament C-zone (Fig. 3A) and that there was a high level of
phosphorylation (~65%) on each of MyBP-C’s four phosphorylatable
serines (14), as seen in healthy human hearts (12, 13). Using total in-
ternal reflectance microscopy with high temporal (8.3 ms) and spatial
(30 nm) resolution, we observed the calcium-dependent sliding of
short ~250-nm native thin filament shards over native thick filaments
(pCa 9 to 5; 25 mM KCl, 100 mMATP, 22°C) (16). This assay preserves
to a large extent the spatial orientations and relationships that exist
between thin and thick filaments in vivo. Thus, the use of the short
thin filaments allows for the observation of actomyosin interactions in
regions of the thick filament with (that is, C-zone) and without MyBP-C.
As with unregulated bare actin filaments (14), at pCa 5 when thin fila-
ments are fully calcium-activated (fig. S3), the thin filaments slide for
643 ± 14 nm (n = 112) along the thick filaments with the majority
(60%, n = 67) sliding with an initial fast phase of velocity, which is
then slowed by MyBP-C as the thin filament enters the C-zone (Fig.
3, A to C). Finally, the thin filament detaches once in the bare zone, where
the thick filament is devoid of myosin heads (Fig. 3, A to C). At cal-
cium concentrations leading to submaxi-
mal thin filament activation (pCa > 5),
the fractions of runs demonstrating bi-
phasic velocities (Fig. 3B) were reduced
(Fig. 3C), and at the lowest calcium con-
centrations (pCa≥ 7) where thin filaments
should be inactive, runs were observed of
constant, slow velocity (Fig. 3D), with short
run lengths (Fig. 3C) nearly equivalent to
that of the C-zone (~475 nm; Fig. 3A).
When compared to the calcium-dependent
motion of thin filaments observed in the
in vitro motility assay using depolymer-
ized mouse cardiac myosin in the absence
of MyBP-C (Fig. 3E, black, and fig. S3B),
the fraction of filaments moving over
wild-type native thick filaments (Fig. 3E,
blue) demonstrated a sigmoidal relation-
ship that was more sensitive to calcium
(pCa50, 6.5 ± 0.04 versus 6.4 ± 0.02; P <
0.05). These data suggest that MyBP-C
increases the number of force-generating
cross-bridges at low calcium concentra-
tions to enhance the thin filament’s effec-
tive calcium sensitivity, as supported by
previous in vitro (8, 9) and muscle fiber
studies (6, 7), but only within the thick
filament C-zone where MyBP-C resides.
MyBP-C’s ability to activate
the thin filament is enhanced
by dephosphorylation
Because thick filaments are highly phos-
phorylated in the normal heart and be-
come dephosphorylated during heart
failure (12, 13), does MyBP-C phospho-
rylation tune MyBP-C’s thin filament ac-
tivating potential? To test this hypothesis,
we treated thick filaments using l-phosphatase, which dephosphoryl-
ated MyBP-C to ~22% (14). Whereas the trajectory run length distri-
butions were similar to the untreated thick filaments (Fig. 3C and fig.
S4), the pCa50 for fraction of thin filaments moving (Fig. 3E; 6.9 ± 0.06
versus 6.5 ± 0.04) increased markedly (P < 0.001), suggesting that de-
phosphorylation enhances MyBP-C’s capacity to effectively sensitize
the thin filament to calcium. Thus, MyBP-C phosphorylation appears
to modulate MyBP-C function. One potential molecular mechanism is
that phosphorylation alters how MyBP-C N-terminal domains inter-
act with and activate the thin filament, which we next characterized
using EM.
MyBP-C’s N-terminal domains displace tropomyosin in a
phosphorylation-dependent manner
Conventional models of thin filament activation suggest that calcium
binding to troponin shifts tropomyosin azimuthally from the “blocked”
to the “closed” position on actin (2, 3), allowing myosin access to the thin
filament. With EM and generated 3D reconstructions (16), we visualized
this calcium-induced shift in tropomyosin position on native thin fila-
ments (Fig. 3, F and G). An expressed (dephosphorylated) MyBP-C
Fig. 2. Sarcomeric calcium gradients in ventricular myocytes. (A) Single cardiac myocyte labeled with
a lipophilic wheat germ agglutinin conjugated to Alexa Fluor 594 to identify t-tubule CRUs. Yellow box
indicates area expanded in (B). (B) Line of yellow arrow represents confocal line scan across several CRUs.
Only confirmed CRUs and their adjacent M-lines were scanned. Yellow boxes represent 5-pixel regions of
interest (ROIs) (500 nm) over the Z- and M-line regions. (C) Rising phase of the calcium transient ([Ca2+]i)
from scanned region depicted in (B) immediately after stimulation of ventricular myocyte loaded with
fluorescent calcium indicator. Certain M-lines are flanked by two adjacent CRUs that release calcium im-
mediately upon stimulation (for example, M2 and M3), whereas others are adjacent to only one CRU that is
triggered (for example, M1 and M4). The inset depicts the spatial profile of [Ca
2+]i 13 ms after stimulation
(vertical yellow line). (D) Average [Ca2+]i transient ± error bars (SEM) rising phase time course from 59
Z-line CRUs (green, n = 12 cells) and their adjacent (adj.) M-lines when flanked by two triggered CRUs
(blue, n = 59 sites, 12 cells) and a single triggered CRU (red, n = 53 sites, 12 cells). (E) Z- to M-line [Ca2+]i
gradient calculated by subtracting M-line from Z-line traces in (D). (F) Z- to M-line [Ca2+]i gradient ± SEM 5,
10, 15, and 20 ms after stimulation in sarcomeres. *P < 0.01, **P < 0.001, one-sample t test.
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N-terminal fragment (C0C3) binds to the thin filament and shifts
tropomyosin to the myosin-accessible, “closed” position even in the
absence of calcium (Fig. 3H and figs. S5 and S6), as recently observed
for the shorter C0C2 fragment (9). In contrast, a C0C3 fragment with
its four phosphorylatable serines replaced by aspartic acid residues (D)
to mimic 100% phosphorylation (C0C3-4D; Fig. 1B) was still capable
of displacing tropomyosin in the absence of calcium but only partially
toward the “closed” position (Fig. 3I and figs. S5 and S6). Although
these data suggest that phosphorylation of all four endogenously phos-
phorylated sites alters MyBP-C’s ability to modulate tropomyosin’s
position on the thin filament, the impact of phosphorylation in vivo
may be more complex given that one or more phosphorylatable sites
may affect MyBP-C’s molecular function differentially (22, 23). The
ability of MyBP-C phosphorylation to modulate the extent of tropo-
myosin displacement (Fig. 3, H and I) provides a molecular mechanism
to tune MyBP-C’s activating potential in the native thick filament (Fig.
3E) or when the N-terminal domains are added to the in vitro motility
assay (fig. S7) (16). MyBP-C appears to be a tunable mechanical ele-
ment within the thick filament that acts synergistically with calcium
through shifts in tropomyosin (Fig. 3, H and I) to modulate levels of
thin filament activation (Fig. 3E). The localization of MyBP-C in the C-
zone of the sarcomere could thus impose a countergradient in activa-
tion to effectively sensitize the thin filament to calcium where the
spatiotemporal gradient of free calcium is greatest (Fig. 2, D to F). Al-
though both calcium and MyBP-C binding independently move
tropomyosin into the “closed” position, myosin strong-binding is re-
quired to displace tropomyosin to the “open” position to cooperatively
amplify and turn on the thin filament for additional myosin binding
(2, 3). Experimental evidence suggests that MyBP-C can also bind to
the S2-domain of the myosin head in a phosphorylation-dependent
manner (6). Such S2 binding affects the positioning of the myosin
head relative to the thick filament (24, 25), which in turn can influence
the attachment and detachment kinetics of myosin to the thin fila-
ment (6, 26). Therefore, MyBP-C binding to the myosin S2-domain
may also effectively sensitize the thin filament to calcium and contrib-
ute to mitigating the functional impact of the calcium gradient. There-
fore, the timing and distance over which myosin strong-binding to the
thin filament can affect thin filament activation both within and out-
side the C-zone requires further experimental consideration.
DISCUSSION
To appreciate the potential spatial effect of both this transient
difference in calcium across the sarcomere and MyBP-C on the acti-
vation state of the thin filament, we developed an analytical model that
uses our data to approximate the thin filament’s activation state over
the length of the thin filament after myocyte stimulation (16). There-
fore, we spatially and temporally modeled the thin filament activation
state by assuming that the fraction of filaments moving was a sensitive
indicator of the thin filament’s activation state rather than velocity, be-
cause changes in thin filament sliding velocities due to MyBP-C may
occur through mechanisms other than changes in the number of at-
tached force-generating cross-bridges (27–30). We then transformed
the [Ca2+]i time course at the Z-line in which the thin filaments insert
and at the M-line adjacent to the C-zone where MyBP-C resides (Fig.
2D) into time courses of relative thin filament activation (that is, frac-
tion of filaments moving) using the sigmoidal-fitted relationship for
Fig. 3. The effects of MyBP-C on native thin filament activation. (A)
Illustration of a thin-filament shard traveling over one-half of a native thick
filament, as in TIRFM experiments. (B) Displacement-time plots for five thin
filaments on wild-type thick filaments at pCa 5 demonstrating two phases
of velocity (black, fast; blue, slow). (C) Trajectory length ± SEM–pCa and
percent trajectories with biphasic velocities (as in B)–pCa histograms for
thin filaments on wild-type thick filaments. (D) As in (B) for five filaments
at pCa 7 demonstrating movement only within the thick filament C-zone.
(E) Fraction of thin filaments moving ± SEM–pCa plots for thin filament
motion in the absence of (black) and presence of wild-type (blue) and
l-phosphatase–treated MyBP-C (red). Data fitted with sigmoidal dose-
response curves with differing pCa50 (P < 0.001, extra sum-squares F test).
Dephos, dephosphorylated with l-phosphatase. (F and G) 3D structure of
native thin filaments with tropomyosin (Tm) in the (F) “blocked” position in
the absence of and (G) “closed” position in the presence of calcium. Atomic
structures of actin with Tm in the “blocked” position (red) and “closed” po-
sition (green) were fitted to each 3D structure. (H and I) 3D structure of
native thin filaments decorated with MyBP-C N-terminal fragments in the
absence of calcium. Position of tropomyosin with addition of (H) C0C3 and
(I) phosphomimetic C0C3-4D fragments. The 3D structure fitted with atomic
structures showed Tm’s movement in thin filament decorated with C0C3
from “blocked” to “closed” position. In contrast, the fitted structures for
the thin filament decoratedwith C0C3-4D showed only partial movement
of Tm toward the “closed” position.
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the fraction of thin filaments moving versus pCa (Fig. 4A). On the
basis of these data, within the initial 15 ms of electrical stimulation
when the calcium gradient is present and at its greatest, the activation
state within the C-zone would be up to 22% less than the region of the
thin filament closest to the calcium release sites near the Z-line (Fig. 4,
A and B). Given the activating potential of natively phosphorylated
MyBP-C (Fig. 3E), MyBP-C within the C-zone is predicted to mitigate
the inhomogeneity in E-C coupling due to the calcium gradient (Fig.
4B) and thus normalize E-C coupling (Fig. 4C) to ensure rapid and
uniform force development within the sarcomere during the early por-
tion of the systolic phase of cardiac contraction. Both this critical role
for MyBP-C and its slowing or “breaking” action (Fig. 3B) would be
reduced or lost in hypertrophic cardiomyopathy patients with MyBP-
C haploinsufficiency (15). In contrast, MyBP-C dephosphorylation, as
observed in failing human hearts (12, 13), is predicted to hypersensi-
tize the thin filament’s activation state by as much as 39% in the C-zone
over the range of calcium we measured (Fig. 4D). This would cause
cardiac cells to maintain considerable levels of activation even during
diastole, resulting in impaired relaxation and decreased ventricular
filling—hallmarks of the failing heart. Reduced diastolic filling limits
ventricular stretch between heartbeats, decreasing normal gains in
force generation that occur through the Frank-Starling mechanism.
Thus, our findings provide a mechanistic explanation for how dephos-
phorylated MyBP-C contributes to impaired relaxation and contractile
dysfunction (31, 32). In conclusion, MyBP-C should be considered a
potential link in the heart’s E-C coupling system that may mechani-
cally compensate for an intrinsic spatial nonuniformity in calcium re-
lease to ensure rapid and efficient activation of the sarcomere.
MATERIALS AND METHODS
Experimental design
The objective of our study was to test the hypothesis that MyBP-C is
localized to a defined and limited region of the sarcomere, the elemen-
tary force-generating unit of the heart, to correct an intrinsic inhomo-
geneity in cardiac E-C coupling. We established a collaborative
multidisciplinary investigative team with expertise in intracellular
cardiac calcium signaling (Lederer Lab), contractile protein molec-
ular biophysics (Warshaw Lab), and contractile protein structural
biology (Craig Lab) to address this question at the subcellular level
using state-of-the-art molecular techniques. We then attempted to
develop an analytical model to illustrate the gross level impact of
MyBP-C in the sarcomere on contractile function in response to
the calcium gradient.
Myofibril isolation and EM imaging
Myofibrils were isolated from the left ventricle of adult 129 SVE mice
for EM imaging of MyBP-C within the sarcomere. The tissue was cut
into small slices in rigor solution containing 100 mM NaCl, 3 mM
MgCl2, 2 mM EGTA, 1 mM NaN3, and 5 mM PIPES (pH 7.0). The
slices were skinned in rigor solution containing 0.1% w/v saponin with
agitation (3 hours, 4°C) and then homogenized with a Polytron homo-
genizer (Brinkmann Instruments) in rigor solution. Myofibrils were
placed on EM grids, blocked with 1% bovine serum albumin (BSA)
in phosphate-buffered saline (PBS), and then incubated with a cMyBP-C
antibody in PBS (gift from S. Harris). For negative staining, grids were
fixed with 2.5% glutaraldehyde (buffered in rigor solution, pH 7.0),
washed with 0.1 M ammonium acetate, and negatively stained with 0.5%
ammonium molybdate. Images were taken on a Tecnai Spirit trans-
mission electron microscope (FEI) with an Erlangshen CCD (charge-
coupled device) camera (Gatan Inc.) at 80 kV.
Cardiomyocyte isolation
Cardiomyocytes were prepared from the left ventricle of adult C57BL/6
mice for dSTORM and confocal imaging as described (33). Cardiomyo-
cytes were stored in a normal Tyrode’s solution containing 140 mM
NaCl, 5 mM KCl, 1.8 mM CaCl2, 0.5 mM MgCl2, 5 mM Hepes, 5 mM
glucose, and 0.33 mM NaH2PO4 (pH 7.4).
Two-color dSTORM super-resolution imaging
dSTORM (34) was performed on murine ventricular myocytes. Im-
munolabeling was performed as previously described (35). Cells were
probed with anti–N-terminal MyBP-C (1:100 dilution, rabbit polyclonal;
sc-67353, Santa Cruz Biotechnology) and anti-RyR2 (1:100 dilution,
mouse monoclonal; C3-33, Pierce) antibodies, followed by labeling with
secondary antibodies (1:500 dilution, goat anti-mouse Alexa Fluor 488
or 647, goat anti-rabbit Alexa Fluor 647, Life Technologies). Images
were captured on a Nikon Eclipse Ti-E inverted wide-field/total inter-
nal reflection fluorescence microscope (TIRFM) using a 100× 1.49 N.A.
(numerical aperture) oil immersion lens. Two-color acquisition was
Fig. 4. Effect of [Ca2+]i on thin filament activation in the absence of
MyBP-C near the Z-line and presence of MyBP-C within the C-zone.
(A) Fraction of thin filaments moving ± SEM–pCa plots within the Z- and
M-line regions of the sarcomere in the (black) absence and (blue) pres-
ence of wild-type (WT) MyBP-C. [Ca2+]i in the Z- and M-line regions 10 ms
after cardiac excitation indicated (green dashed lines). (B to D) Model gen-
erated estimates of thin filament activation after calcium release. Thin
filament activation–time plot generated for regions of the thin filaments
near the Z-lines (black) and within the C-zone, near the center of the
sarcomere. (B) Model assumes that the C-zone lacks MyBP-C and thus
predicts that thin filament activation in the C-zone (gray) would lag be-
hind the Z-line. (C) Model assumes normally phosphorylated wild-type
MyBP-C in C-zone (blue) and predicts that C-zone activation level would
no longer lag behind the Z-line. (D) Model assumes dephosphorylated
MyBP-C within C-zone (red), resulting in a sensitized C-zone that would
contribute to significant activation even during relaxation.
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performed in an interlaced fashion, with images collected at 55 frames/s
on an 897 Ultra EMCCD camera (Andor Technology). A minimum of
40,000 single-molecule events were detected per field of view, and super-
resolution images were reconstructed from Gaussian fits to these single-
molecule events.
T-tubule and calcium imaging
Cells were loaded with Fluo-4 by 15-min incubation with 3 mM Fluo-
4–acetoxymethyl ester (Life Technologies) and 0.01% Pluronic F127 (a
poloxamer made by BASF Corporation) and allowed an additional
10 min for de-esterification. Cells were additionally stained with the
lipophilic t-tubule marker wheat germ agglutinin conjugated to
Alexa Fluor 594 (WGA-594, Life Technologies). All experiments were
performed in custom, rotatable glass-bottomed cell chambers (Four
Hour Day Foundation) equipped with local and bath perfusion, and
platinum electrodes for field stimulation at 1 Hz. Cells were imaged on
a LSM 5 LIVE inverted ultrahigh-speed confocal microscope using a 63×
1.4 N.A. water immersion objective (Zeiss). Loading of indicators and
experiments was performed at room temperature (22 ± 1°C). First,
WGA-594 was excited and imaged using a 563-nm diode laser. After
t-tubule CRUs were located, a confocal line scan was placed over 7 to
15 CRUs in series. This region of the cell was then scanned using a
488-nm argon ion laser in confocal line scan mode at 200 ms per line.
This scan speed and chemical indicator combination was found to
produce the best signal/noise and necessary temporal resolution to re-
solve sarcomeric calcium gradients. Pixel size was 0.1 mm, and 500-nm
(5-pixel) ROIs were placed over the known CRUs at the Z-line or their
directly adjacent M-lines, and the fluorescence time course after field
stimulation was calculated for each ROI. Fluorescence time courses
were converted to F/F0, with F0 the resting (before stimulation) fluo-
rescence for each ROI to control for dye loading and potential com-
partmentalization. The calibration of the fluorescence signal (F) to
[Ca2+]i from a single wavelength indicator was done using the
following equation: [Ca2+] = Kd(F − Fmin)/(Fmax − F) as described
(36), where Fmin is the fluorescence intensity in the absence of Ca
2+
and Fmax is the fluorescence in the presence of saturating Ca
2+. Fmin
was achieved by perfusing the cell with a normal Tyrode’s solution
lacking CaCl2 with the following additions: 25 mM cytochalasin D (to
inhibit contraction), 2 mM calcium ionophore ionomycin, and 10 mM
EGTA. Fmax was achieved by perfusing the cell with normal Tyrode’s so-
lution with 25 mM cytochalasin D, 2 mM ionomyocin, and 10 mMCaCl2.
A Kd (dissociation constant) of 891 nM was used as recently measured
for Fluo-4 in the presence of protein (37).
Protein preparation
Native thick and thin filaments were isolated for from the apex of
adult FVB mouse hearts as described (9, 14). Briefly, sarcomeric pro-
teins were purified by serial mechanochemical extractions. The native
thick filaments were liberated from 5 to 10 small bundles of muscle
strips by digestion in a 10-ml drop containing 0.2 U/ml of calpain-1 from
porcine erythrocytes (Calbiochem). The thick filaments were stored in
250 ml of chilled 75 mM NaCl, 5 mM MgCl2, 2 mM EGTA, 1 mM
DTT (dithiothreitol), 7 mM phosphate buffer (pH 7), 10 mM creatine
phosphate, and 2.5 mM ATP. Although MyBP-C is a target for calpain-
induced degradation, this procedure results in 79% of the MyBP-C being
intact (14). For dephosphorylation experiments, 50-ml aliquots of thick
filament samples were incubated with 5 ml (2000 U) of l-phosphatase
from Escherichia coli (New England BioLabs) and 6.5 ml of 10 mM
MnCl2 (1 hour, 30°C) to decrease the phosphorylation of the endog-
enous MyBP-C to 22% (14). Native thin filaments were liberated from
muscle strips by serial extraction through homogenization and centrif-
ugation. The thin filaments were stored in chilled 100 mM KCl, 5 mM
MgCl2, 1 mM EGTA, 25 mM imidazole (pH 6.45), and 10 mM DTT.
The thin filaments were fluorescently labeled with tetramethyl rho-
damine phalloidin and diluted in actin buffer [25 mM KCl, 1 mM
EGTA, 10 mM DTT, 25 mM imidazole, and 4 mM MgCl2, adjusted
to pH 7.4; containing an oxygen scavenging system [glucose oxidase
(0.1 mg/ml), catalase (0.018 mg/ml), and glucose (2.3 mg/ml)]. Before
use, 1.5-ml tubes containing 1 ml of 0.01 mMTRITC (tetramethyl rho-
damine isothiocyanate)–labeled thin filaments in actin buffer were so-
nicated for 20, 1-s pulses using a probe sonicator (Model 300, Fisher)
to produce ~250-nm thin filament shards (14).
For the in vitro motility assays, monomeric myosin was freshly
isolated from the ventricles of FVB mouse hearts as described (9, 14).
Cardiac MyBP-C N-terminal C0C3 (amino acids 1 to 539) and phos-
phomimetic C0C3-4D fragments were bacterially expressed as de-
scribed (9, 14). The C0C3-4D fragment contained phosphomimetic
aspartic acid residues in place of the four phosphorylatable serines
(S273, S282, S302, and S307) located within the M-domain.
Fluorescence image acquisition
All native thin filament sliding assays were performed at room tem-
perature (22 ± 1°C) using a Nikon Eclipse Ti-U inverted microscope
equipped with a Plan Apo 100× 1.49 N.A. oil emersion lens for epi-
fluorescence or through-the-objective total internal reflectance micros-
copy (TIRFM) using a custom “Micro Optic Fiber Launch TIRFM”
(patent pending) as described (14). Briefly, either a Lumen 200-W
metal arc lamp (Prior Scientific) or 532-nm diode-pumped, solid-state,
50-mW laser (Lasever Inc.) was used for excitation. Images were obtained
using an intensified high-resolution 10-bit digital camera (XR/Turbo-Z
running Piper Control v2.6.09 software, Stanford Photonics).
In vitro motility assay
To determine the calcium sensitivity of the native thin filaments, in vitro
motility assays were performed on the surface of a flow cell coated with
mouse cardiac myosin (100 mg/ml) with the calcium-dependent motion
of the filaments observed by epifluorescence microscopy as described
(9). Motility buffer (actin buffer with 100 mM ATP, 0.5% methyl cel-
lulous, and calcium chloride ranging from pCa 4 to 9) was added to
the flow cell, and thin filament motion was observed after 3 min of
incubation. Calcium levels were determined using MaxChelator soft-
ware (38) to account for the 1 mM EGTA present in the motility buf-
fer. Images were captured at 10 frames/s and down-sampled to 2 frames/s
using ImageJ 1.43u (National Institutes of Health), and DiaTrack 3.03
software for Windows (Semasopht) was used to determine their velocity
and fraction of moving thin filaments. The mean velocity and fraction
moving ± SEM were determined from the average of four movies for
each experimental condition from a minimum of three independent
myosin and native thin filament preparations. The velocity and frac-
tion of filaments moving were plotted with respect to pCa (negative
log of the calcium concentration) and fitted with sigmoidal dose-response
curves with variable slopes using GraphPad Prism 6 (GraphPad Soft-
ware). To determine the effect of MyBP-C’s N-terminal C0C3 and
phosphomimetic C0C3-4D domains on thin filament activation and
inhibition of maximal sliding velocities, we added the fragment into
the motility buffer, over a range of fragment concentrations.
R E S EARCH ART I C L E
Previs et al. Sci. Adv. 2015;1:e1400205 20 February 2015 6 of 8
 o
n
 O
ctober 30, 2015
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
Thick filament assay
The movement of ~250-nm TRITC-labeled native thin filament shards
was observed on native thick filaments from three independent thick
and thin filament preparations using TIRFM as described for bare
actin filaments (14). Thick filaments were incubated in a Sigmacote-
treated glass flow cell (20 min). The surface of the flow cell was
blocked with BSA (1 mg/ml) for 3 min and then washed with actin
buffer containing 1 mM ATP. A 30-ml aliquot of 0.01 mM TRITC-
labeled thin filament shards in actin buffer without ATP or calcium
was infused into the flow cell, incubated for 1 min, and then washed
with actin buffer. The flow cell was oil-coupled to the microscope
objective, and the TRITC-labeled thin filaments were visualized using
TIRFM. Next, three 30-ml aliquots of 0.01 mM TRITC-labeled actin
shards in actin buffer with 100 mM ATP and calcium chloride ranging
from pCa 5 to 9 were sequentially added to the flow cell in a ran-
dom order. Thin filament motility on thick filaments was recorded
(120 frames/s, 1000 frames) at each pCa in multiple areas on the
flow cell. The image stacks were processed using ImageJ SpotTracker
2D with spatial resolution being 30 nm as reported (14). The X- and
Y-positions of linear tracks less than 800 nm in length were recorded
in Excel (Microsoft). The instantaneous velocity of each thin filament
was plotted using GraphPad Prism 6 (GraphPad Software) and fitted
with a segmental linear regression to determine if there was one or
two phases of velocity as described (14). The fraction of filaments
moving from pCa 6 to 9 in each 1000 frame acquisition was deter-
mined relative to the average number of filaments moving at pCa 5.
The average percent moving ± SEM was reported. The data were fitted
with a sigmoidal dose-response curve with variable slopes (GraphPad
Prism 6) to determine the effective pCa50. Statistical significance be-
tween fitted data was determined by the extra sum-squares F test.
3D electron micrograph reconstructions
EM and 3D reconstructions were carried out on native thin filaments
as described (9). In brief, for control measurements of tropomyosin in
the “blocked” position, native thin filaments were diluted in low-Ca2+
buffer [100 mM K acetate, 2 mMMgCl2, 0.2 mM EGTA, 1 mM DTT,
and 10 mM MOPS (pH 7.0)]. For high-Ca2+ controls with tropomyosin
in the “closed” position, 100 mMCaCl2 was added to the buffer (to total
0.33 mM Ca2+). For decoration with MyBP-C N-terminal fragments,
2 mM native thin filaments were mixed with 6 mM C0C3 (actin sub-
units/C0C3,1:3) in low-Ca2+ buffer. After mixing, solutions were in-
cubated at room temperature for 30 min, applied to EM grids, and
negatively stained with 1% uranyl acetate (39). Thin filaments were ob-
served with a Philips CM120 electron microscope (FEI) at 80 KV un-
der low-dose conditions, with images acquired at a pixel size of 0.35 nm,
using a 2 K × 2 K CCD camera (F224HD, TVIPS GmbH). Not all
filaments were well decorated by C0C3. The most strongly decorated
were selected on the basis of the increase in their diameter due to
bound C0C3 (9). Long, relatively straight filaments were unbent using
ImageJ (National Institutes of Health) and converted to SPIDER for-
mat (EM2EM; Image Science and Imperial College, London). A den-
sity projection along the filament axis was obtained using the SPIDER
(v11.2) software package (40) to determine the diameter calculated from
the distance between the minima in the projection profile. Selected fila-
ments were cut into segments in SPIDER (40), and Iterative Helical Real
Space Reconstruction (IHRSR) (41) was carried out using SPIDER (40).
An F-actin model (no tropomyosin) was used as an initial reference for
the first round of IHRSR so that the model would not bias the position
of tropomyosin in the reconstruction. UCSF Chimera (42) was used
for visualization, analysis, and atomic fitting of 3D volumes. Accurate
matching of 3D reconstructions was carried out by fitting each recon-
struction to the same-reference F-actin model; comparison of different
reconstructions, all fitted to the same-reference F-actin model, re-
vealed any changes in tropomyosin position (9). The reconstructions
were fitted with atomic models of F-actin and/or F-actin–tropomyosin
determined by x-ray diffraction and cryo-EM (43, 44).
Modeling
An analytic model was developed to predict the spatial impact of the
calcium gradient on the activation state of the thin filament in regions
of the sarcomere with and without MyBP-C and on MyBP-C’s phos-
phorylation state (Fig. 4). To model the relative levels of thin filament
activation as a function of time after stimulation near the Z-line
(region lacking MyBP-C) and within the C-zone (where MyBP-C re-
sides), we used the [Ca2+]i time course at the Z-line and M-line, re-
spectively (Fig. 2D), and plotted the fraction of filaments moving at
each concentration using the sigmoidal-fitted fraction of thin filaments
moving–pCa curves (Fig. 4A) as a measure for activation. The resultant
predicted levels of thin filament activation within these two sarcomeric
regions were plotted with respect to time (Fig. 4, B to D).
Statistical analysis
Average [Ca2+]i transients were determined from 59 Z-line and M-line
regions flanked by two CRUs and 53 Z-line and M-line regions flanks
by one CRU originating from 12 cardiac myocytes (Fig. 2E). Z- to M-line
[Ca2+]i differences were determined by subtracting 5, 10, 15, and 20 ms
after stimulation in each trace (Fig. 2F). Statistical differences were
determined by a one-sample t test.
The average percentage of thin filaments moving with respect to
calcium was determined in the absence of MyBP-C in the in vitro mo-
tility assay in four movies at each calcium concentration from three
independent protein preparations and normalized to 100% of the fila-
ments moving at pCa 4 to 5. The average fraction of filaments moving
on native thick filaments and l-phosphatase–treated thick filaments
was determined from five movies at each calcium concentration rela-
tive to the movement at pCa 5. Each data set was fitted with a sigmoidal
dose-response curve with variable slopes (GraphPad Prism 6). Statistical
significance between the effective pCa50 for each curve was determined
by the extra sum-squares F test.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/1/1/e1400205/DC1
Materials and Methods
Fig. S1. Two-color dSTORM super-resolution imaging of MyBP-C and ryanodine receptors (RyR2).
Fig. S2. Treatment with the contractile inhibitor blebbistatin does not obscure sarcomeric calcium
gradients.
Fig. S3. Calcium-dependent regulation of native thin filament motion.
Fig. S4. Histograms for thin filaments on l-phosphatase–treated thick filaments containing
dephosphorylated MyBP-C (trajectory length ± SEM and percent trajectories with biphasic
velocities versus pCa).
Fig. S5. 3D reconstructions of low-Ca2+ native thin filaments decorated with C0C3 (actin/C0C3,1:3)
in which the four phosphorylatable serines have been replaced with alanines (fully dephosphoryl-
ated, C0C3-4A) or with aspartic acid residues (phosphomimetic, C0C3-4D).
Fig. S6. Transverse sections of the respective low-Ca2+ reconstructions in fig. S5, in which na-
tive thin filaments have been decorated with C0C3-4A and C0C3-4D.
Fig. S7. Phosphorylation of MyBP-C N-terminal domains modulates their ability to activate
native thin filament motion in the in vitro motility assay on a bed of monomeric myosin.
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